ClinicalTrials.Veeva

Menu

Platelet-rich Plasma for Menical Tear

U

University of Malaga

Status

Unknown

Conditions

Meniscus Lesion
Platelet-Rich Plasma

Treatments

Procedure: Platelet-rich plasma (PRP) therapy

Study type

Observational

Funder types

Other

Identifiers

NCT04040283
UMalaga21

Details and patient eligibility

About

Meniscal injuries are a common pathology among athletes, and have an impact on the daily or sporting practice of patients. Surgical approach implies sometimes heavy consequences. Platelet-rich-plasma (PRP) has been shown to be effective in accelerating wound healing and tissue regeneration in orthopedic and oral surgery. This clinical trial aims to investigate the safety and efficacy of intraarticular and periferal PRP injection in patients with stable meniscal injury. The pre- and post-interventional clinical outcomes will be compared.

Enrollment

15 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Skeletally mature patients 18-70 years of age
  • With diagnosis of meniscus injury
  • Single tear of the medial and/or lateral meniscus
  • With no indication of meniscus repair surgery

Exclusion criteria

  • Prior history of multiple ligaments injury, associated significant ligament instability: Grade III MCL, Grade III PCL, or ACL deficient knee
  • Prior history of knee surgery
  • Discoid meniscus
  • Osteoarthritic changes (Kellgren Lawrence scale >2)
  • Inflammatory diseases (i.e. rheumatoid arthritis)
  • Underlying bleeding disorder or coagulopathy
  • Concominant chondral defects (> 2 ICRS)
  • Cancer patients
  • Pregnancy
  • Patients who will not cooperate with six-month followup

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems